Organisation paid for research Program year 2024 Source: CMS Open Payments

Florida Heart Center

Neither a doctor nor a teaching hospital

Research payments

$313,737

43 payments

Through program year 2024, Florida Heart Center is reported as receiving $313,737 in research payments, across 43 payments.

By program year

6 rows
Year Kind Amount Payments
2024 Research $91,877 10
2023 Research $64,163 10
2022 Research $64,423 10
2021 Research $45,069 8
2020 Research $41,955 4
2019 Research $6,250 1

Breakdown

Who paid Research payments · program years 2019–2024
  1. Medtronic, Inc. $265,032 37 payments
  2. Medtronic Vascular, Inc. $41,955 4 payments
  3. Amgen Inc. $6,250 1 payment
  4. Novartis Pharmaceuticals Corporation $500 1 payment
Studies the money was for Research payments · program years 2019–2024
  1. Alleviate-Hf $306,987 41 payments
  2. Cognitive Interview of Subject With Heart Failure to Further Evaluate the Content of the Amgen Chronic Heart Failure Symptom and Impact PRO Measure $6,250 1 payment
  3. Observational Registry of Treatment Patterns in US Heart Failure Patients With Reduced Ejection Fraction $500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record